The treatment of BD in children is similar to that of adult BD. First, we treat whatever the episode that is being experienced – acute phase treatment – and when things get better we focus on preventing future episodes – maintenance phase treatment. Most of the medications for both phases are the same. One must also keep in mind that BD children often have comorbid (additional) diagnoses which might need treatment, as well.
Acute Phase Treatment
The acute phase of treatment of BD means medicating a child who is either manic or depressed (but depressed with a history of mania or hypomania) or one who has TDD.
The initial acute phase treatment for mania without psychotic features (hallucinations and delusions), or TDD starts with monotherapy treatment with one drug. The one drug is either a mood stabilizer such as Lithium, Depakote, or Tegretol, or less commonly Gabapentin, Trileptal, or Topamax, or an antipsychotic drug such as Risperdal, Seroquel or Zyprexa, or less commonly Abilify or Geodon. If a child only partially responds than an augmenting agent is often tried in conjunction with the first medication. Usually this consists of adding an antipsychotic to a mood stabilizer or conversely a mood stabilizer to an antipsychotic. Alternatively, if the child does not respond to monotherapy the psychiatrist sometimes skips the augmentation phase and just switches to another of the original choices of monotherapy listed above. Again, there is still an opportunity to add an augmenter. If the child still fails to respond than differing combinations of mood stabilizers and antipsychotics are often tried. On the whole most children do respond to one or more of the more common first line drugs (Lithium, Tegretol, Depakote or Risperdal, Seroquel or Zyprexa).
For BD children with psychotic features, it is common to start with a combination of a mood stabilizer and an antipsychotic drug. If this fails the psychiatrist can switch the combination of these drugs, and then add another antipsychotic medication or add another mood stabilizer. Finally, if all combinations of the common mood stabilizers and antipsychotics are exhausted, less effective mood stabilizers in conjunction with different antipsychotic medications may be prescribed.
Maintenance Phase Treatment
The maintenance phase of drug therapy is aimed at preventing recurrence of episodes of BD. Interestingly the maintenance drugs are the same ones used in the acute phase of treatment. There is little evidence that these drugs work as well in preventing relapses in young people as they do in adults. The maintenance phase usually lasts from one to two years and depends, to a degree, on the level of impairment, the chronicity of the condition, the number of episodes of bipolarity, and the level of stability reached by the youth and the environment in which she lives. While most young patients are able to get off these medications, there will be times that this will prove impossible. Sometimes relapse follows quickly upon stopping the medications. As with some adults, a decision will be made that drug therapy will be maintained indefinitely to help the child or adolescent progress in life, socially, educationally, and vocationally without the risk of further decompensation.
DISCLAIMER
Information contained in this blog is intended for educational purposes only. It is not intended as medical or psychiatric advice for individual conditions or treatment and does not substitute for a medical or psychiatric examination. A psychiatrist must make a determination about any treatment or prescription. Dr. Paul does not assume any responsibility or risk for the use of any information contained within this blog.